Novartis AG is 214.9x more valuable than Bicara Therapeutics Inc. by market capitalization ($283.13 B vs $1.32 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BCAX | NVS |
|---|---|---|
| Market cap | $1.32 B | $283.13 B |
| US-listed rank | #2429 | #47 |
| Net income (latest FY) | -$137.95M | - |
| SEC filings | 221 | 947 |
Novartis AG is 214.9x more valuable than Bicara Therapeutics Inc. by market capitalization ($283.13 B vs $1.32 B).
Full pages: Bicara Therapeutics Inc. and Novartis AG, or browse the full rankings.